| Primary |
| Product Used For Unknown Indication |
41.3% |
| Gout |
25.8% |
| Behcet's Syndrome |
6.0% |
| Hypertension |
3.5% |
| Familial Mediterranean Fever |
2.4% |
| Pneumonia |
2.2% |
| Arthralgia |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Overdose |
1.9% |
| Pain |
1.9% |
| Renal Transplant |
1.4% |
| Asthma |
1.1% |
| Back Pain |
1.1% |
| Bipolar Disorder |
1.1% |
| Constipation |
1.1% |
| Depression |
1.1% |
| Gastrointestinal Infection |
1.1% |
| Gouty Arthritis |
1.1% |
| Hypothyroidism |
1.1% |
| Renal Failure Chronic |
1.1% |
|
| Vomiting |
17.7% |
| Toxicity To Various Agents |
15.9% |
| Diarrhoea |
12.4% |
| Renal Failure Acute |
9.7% |
| Alanine Aminotransferase Increased |
3.5% |
| International Normalised Ratio Increased |
3.5% |
| Renal Failure |
3.5% |
| Weight Decreased |
3.5% |
| Aspartate Aminotransferase Increased |
2.7% |
| Cardiac Arrest |
2.7% |
| Drug Ineffective |
2.7% |
| Drug Interaction |
2.7% |
| Malaise |
2.7% |
| Myopathy |
2.7% |
| Neuromyopathy |
2.7% |
| Rhabdomyolysis |
2.7% |
| Urticaria |
2.7% |
| White Blood Cell Count Increased |
2.7% |
| Accidental Exposure |
1.8% |
| Back Pain |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
36.3% |
| Gout |
13.5% |
| Behcet's Syndrome |
13.3% |
| Drug Use For Unknown Indication |
9.8% |
| Hypertension |
4.2% |
| Prophylaxis |
3.1% |
| Diabetes Mellitus |
2.0% |
| Pain |
1.9% |
| Depression |
1.7% |
| Seasonal Allergy |
1.7% |
| Uveitis |
1.7% |
| Completed Suicide |
1.7% |
| Type 2 Diabetes Mellitus |
1.3% |
| Atrial Fibrillation |
1.3% |
| Arthralgia |
1.2% |
| Myocardial Ischaemia |
1.2% |
| Coronary Artery Disease |
1.1% |
| Vasculitis |
1.1% |
| Cardiac Failure |
1.0% |
| Rheumatoid Arthritis |
0.9% |
|
| Completed Suicide |
16.3% |
| Renal Failure Acute |
10.3% |
| Toxicity To Various Agents |
8.8% |
| Pancreatitis Acute |
8.3% |
| Vomiting |
8.3% |
| Drug Interaction |
7.0% |
| Rhabdomyolysis |
5.0% |
| Thrombocytopenia |
4.8% |
| Death |
4.5% |
| Diarrhoea |
3.5% |
| Oedema Peripheral |
3.0% |
| Renal Failure |
2.8% |
| Sepsis |
2.8% |
| Weight Decreased |
2.8% |
| Nausea |
2.3% |
| Stevens-johnson Syndrome |
2.3% |
| Leukopenia |
2.0% |
| Metabolic Acidosis |
2.0% |
| Suicide Attempt |
2.0% |
| Cytolytic Hepatitis |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.3% |
| Drug Use For Unknown Indication |
19.7% |
| Gout |
9.3% |
| Behcet's Syndrome |
7.4% |
| Hypertension |
6.7% |
| Prophylaxis |
4.0% |
| Pain |
3.3% |
| Rheumatoid Arthritis |
2.7% |
| Diabetes Mellitus |
2.6% |
| Atrial Fibrillation |
1.8% |
| Multiple Myeloma |
1.6% |
| Type 2 Diabetes Mellitus |
1.5% |
| Depression |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Osteoporosis |
1.3% |
| Arthritis |
1.2% |
| Pulmonary Arterial Hypertension |
1.2% |
| Insomnia |
1.2% |
| Constipation |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
|
| Vomiting |
13.3% |
| Weight Decreased |
11.8% |
| Renal Failure Acute |
6.2% |
| Gout |
6.1% |
| Urinary Tract Infection |
5.6% |
| Weight Increased |
4.9% |
| Death |
4.8% |
| Renal Failure |
4.7% |
| Myocardial Infarction |
4.3% |
| Thrombocytopenia |
4.1% |
| Drug Ineffective |
3.9% |
| Pneumonia |
3.7% |
| Pain In Extremity |
3.5% |
| Pruritus |
3.5% |
| Rhabdomyolysis |
3.5% |
| Pyrexia |
3.4% |
| Rash |
3.4% |
| Therapeutic Response Decreased |
3.4% |
| Oedema Peripheral |
3.1% |
| Sepsis |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
48.5% |
| Gout |
10.8% |
| Coronary Artery Disease |
6.0% |
| Drug Use For Unknown Indication |
3.8% |
| Heart And Lung Transplant |
3.8% |
| Bronchiolitis |
3.5% |
| Hyperuricaemia |
3.1% |
| Gouty Arthritis |
2.9% |
| Heart Transplant |
2.1% |
| Tooth Abscess |
2.1% |
| Behcet's Syndrome |
1.8% |
| Arthralgia |
1.7% |
| Asthma |
1.7% |
| Renal Transplant |
1.7% |
| Pneumonia |
1.5% |
| Hypertension |
1.3% |
| Familial Mediterranean Fever |
1.1% |
| Synovitis |
1.1% |
| Atrial Fibrillation |
1.0% |
| Dyslipidaemia |
0.8% |
|
| Drug Interaction |
23.0% |
| Toxicity To Various Agents |
15.8% |
| Cardiac Arrest |
7.2% |
| Renal Failure Acute |
6.6% |
| Rhabdomyolysis |
5.3% |
| Gastrointestinal Disorder |
4.6% |
| Renal Failure |
4.6% |
| Muscular Weakness |
3.3% |
| Neutropenia |
3.3% |
| Incorrect Dose Administered |
2.6% |
| Multi-organ Failure |
2.6% |
| Myopathy |
2.6% |
| Pancytopenia |
2.6% |
| Thrombocytopenia |
2.6% |
| Weight Decreased |
2.6% |
| White Blood Cell Disorder |
2.6% |
| Agranulocytosis |
2.0% |
| Cytolytic Hepatitis |
2.0% |
| Fall |
2.0% |
| Potentiating Drug Interaction |
2.0% |
|
